Full-Time

Senior Corevalve Therapy Consultant

Multiple Teams

Posted on 10/11/2025

Deadline 10/14/25
Medtronic

Medtronic

10,001+ employees

Medical device maker advancing therapies

Compensation Overview

$100k/yr

+ Sales Incentive Plan

Cincinnati, OH, USA

Remote

Candidate must reside within the territory and drive to multiple accounts throughout the region.

Category
Sales & Account Management (1)
Requirements
  • Bachelor degree
  • 5+ years medical industry sales experience (selling physician preference products) in healthcare environment, OR
  • 3+ years of B2B sales and 2+ years medical industry sales, OR
  • 3+ years TDS experience or STEP Program graduate and 2+ years of medical industry sales
  • Must have a valid driver's license and active vehicle insurance policy. In addition, your driving record will be reviewed and will be considered as part of your application
Responsibilities
  • Territory Management and Account Development
  • Provide quality support to help sites achieve procedural success and for the safe growth of CoreValve
  • Develop and post approval, execute strategies and plans to achieve/exceed sales quota for commercial cases. Maintain and expand existing business and develop new business opportunities
  • Serve as trusted technical expert for TAVR procedure and products. Provide technical support for TAVR implanting centers, including 'scrubbing in' to assist with valve loading and providing technical case support consistent with the instructions for use. Educate sites on proper indications for TAVR procedures
  • Probe to understand and confirm customers’ needs, handle objections and gain commitment. Develop and implement strategies to counter competitor messaging
  • Educate customers to ensure that products are understood and used effectively
  • Represent company at industry conferences and maximize potential by targeting specific customers to gain sales leads, and pursue opportunities to promote the company’s product portfolio
  • Knowledge of CoreValve and other Medtronic TAVR product IFUs for safe and effective use of devices
  • Develop and maintain comprehensive clinical and technical product knowledge. Understands current published TAVR and relevant literature. Recognize and understand competitive products, industry trends, and CBT/CVG portfolio. Liaison with R&D for technology improvements and next generation needs
  • Provide quality technical support to help sites achieve procedural success
  • Provide technical support to Medtronic employees and implanting teams for CoreValve implant procedures in accordance with Medtronic guidance
  • Provide technical leadership for TAVR device procedures. Educate implanting teams on proper indications for TAVR procedures. Provide support on questions regarding device suitability with measuring ability and CT reconstruction expertise. Provide comprehensive technical support including knowledge of imaging modalities (echo/angiography/CT), EKG, blood pressure, wave forms, and ancillary procedural solutions
  • Ensure maximum coverage of all accounts within territory geographic areas to maintain optimum level of exposure and effective time management. Assist with scheduling of cases and proper customer support
  • Participate in physician training and case observations when necessary
  • Participates in any other planned customer education meetings and society conventions
  • Respond to customer requests and resolve complaints in a prompt and effective manner to include proper device complaint reporting
  • Maintain high standards of personal presentation and promote a professional personal and company image
  • Assist sites with identifying routine implant days and proper case scheduling
  • Develop and maintain accurate account and territory records
  • Responsible for CoreValve inventory at sites to include shipments, usage and return of product
  • Responsible for forecasting implants at sites and obtaining billing PO’s for each case
  • Submits accurate and timely expense reports
  • Report device complaints to proper departments within quality assurance within Medtronic
  • Schedules travel arrangements to ensure multiple objectives are accomplished
  • Supports heart teams with appropriate products, clinical literature and pre case planning strategy
  • Maintain hospital eligibility/access with various vendor credentialing services
  • Control expenses and adhere to company policies and procedures
  • Identify, establish and maintain productive working relationships with key decision makers, customers and their staff, administrative staff, etc.
  • Maintains a high level of communication with appropriate CVG sales and leadership within assigned geography
  • Plan and implement effective sales/product presentations to customers
  • Develop and maintain productive working relationships within the company to ensure maximum sales support and maintain a high level of customer service
  • Contribute to the development of a strong team effort
  • Communicate market intelligence/competitor activity promptly, including potential sales leads, and information regarding product price or account activity to District Manager and Clinical or other appropriate company personnel
  • Ensure a professional standard of written and verbal communication at all times
Desired Qualifications
  • Demonstrated success in previous sales role; indicating a high level of sales performance, influence and selling skills
  • Exceptional business and clinical acumen with prior experience leading a sophisticated cardiac or endovascular procedure
  • Exceptional understanding of cardiac and vascular anatomy, physiology, and pathology
  • Interventional cardiac or vascular experience (wires, balloons, catheters, stents)
  • Endovascular - specifically Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aneurysm Repair (TEVAR) - or Cardiac surgery, Surgical Aortic Valve Replacement (SAVR) experience preferred
  • Strong, proven medical device sales track record with documented growth and achievements
  • Previous experience communicating product’s market advantages to physicians and hospital administration
  • Experience managing multiple accounts
  • Successful experience launching a new device
  • Market development experience
  • Experience calling on C-Suite customers
  • Prior experience teaching and educating medical personnel, peers and technical support personnel
  • Imaging interpretation experience (TTE or Trans Esophageal Echocardiography (TEE), CT, Angiograms). Computer proficiency and ability to perform CT reconstruction with CT programs
  • Demonstrated success building strong relationships with key therapy users and employees across organizational level
  • Ability to effectively organize and plan travel schedule with frequent last minute requests
  • Ability to travel with overnight stay up to 50 - 75% of the time (geography variability)
  • Previous peer and physician education experience
  • Excellent influencing and consulting skills
  • Excellent interpersonal and written communication skills
  • Ability to make timely and sound decisions

Medtronic makes medical devices and therapies to treat chronic diseases, including implantables, sensors, and diabetes management tools. Its devices interact with the body to regulate or monitor functions, such as pacemakers delivering heart stimulation and neuromodulation devices sending electrical signals. The company differentiates itself through a long history of device development and a broad portfolio, expanded via acquisitions to access new technologies and markets. Its goal is to improve patient health outcomes by providing integrated medical technologies that help manage chronic conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • MiniMed separation could unlock value for Medtronic's diabetes business.
  • Galway software hub strengthens cloud-based cardiac monitoring and clinical software capabilities.
  • SPR Therapeutics adds temporary peripheral nerve stimulation to neuromodulation.

What critics are saying

  • Electrophysiology rivals can steal physician adoption from Medtronic's ablation growth engine.
  • Tariff costs already pressure fiscal 2027 margins and earnings.
  • MiniMed IPO execution will expose diabetes franchise weakness if pricing disappoints.

What makes Medtronic unique

  • 1949 garage roots produced Medtronic's first wearable, battery-powered pacemaker.
  • Acquisitions, especially Covidien in 2015, transformed Medtronic into a broad-device platform.
  • Cardiac ablation reached a $2 billion annualized run rate in fiscal 2026.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Medtronic who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Investing.com
Jun 3rd, 2026
Medtronic invests in two ICE catheter technology companies By Investing.com

Medtronic invests in two ICE catheter technology companies

Yahoo Finance
Apr 10th, 2026
GE HealthCare and Medtronic launch integrated neurosurgery imaging and navigation system

Medtronic and GE HealthCare have launched a digital integration combining GE's bkActiv intraoperative ultrasound with Medtronic's Stealth AXiS surgical navigation system for cranial neurosurgery. The commercially available system provides real-time imaging during procedures, connecting Medtronic's navigation and robotics platforms with GE HealthCare's imaging technology. The integration aims to enhance clinical decision-making during complex cranial procedures through precise guidance and visualisation. It may influence hospital equipment purchasing decisions, surgeon productivity and operating room efficiency. Medtronic currently trades at $87.91, approximately 19.8% below the $109.64 analyst target range midpoint. The stock has experienced a 2.2% decline over the past 30 days. Adoption rates amongst surgeons and hospitals, alongside hospital capital spending on neurosurgery suites, will be key factors to monitor.

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Yahoo Finance
Apr 7th, 2026
Stifel cuts Medtronic price target to $95 from $105 on MiniMed IPO dilution

Stifel has lowered its price target on Medtronic (NYSE:MDT) to $95 from $105, maintaining a Hold rating. The adjustment reflects transaction-related impacts from the 9 March IPO of Medtronic's Diabetes business, now called MiniMed. MiniMed will remain a consolidated subsidiary until formal separation, expected about six months post-IPO. Stifel continues to model full Diabetes business revenue whilst adjusting for the 10% non-controlling interest sold in the IPO. Management expects IPO-related earnings per share dilution of 1-2 cents monthly until separation completes. Separately, the US Food and Drug Administration recently cleared Medtronic's Stealth AXiS surgical system for cranial and ear, nose and throat procedures, expanding beyond its earlier spine indication.

Silicon Republic
Apr 3rd, 2026
What impact might Medtronic's new lab have on Galway's medtech ecosystem?

What impact might Medtronic's new lab have on Galway's medtech ecosystem? 3 Apr 2026 From left: Ruth Callanan, Ronan Rogers and John Caulfield. Image: Andrew Downes/Xposure Ronan Rogers and Ruth Callanan discuss innovation in the west of Ireland and the evolution of Ireland's STEM careers. Ireland's medtech sector is moving beyond traditional biomedical engineering, according to Ronan Rogers, the senior R&D director for cardiac ablation solutions at Medtronic. He explained the region has built "real depth", not just in medtech, but across key areas such as pharmaceutical science, advanced analytics and digital technology. Areas that are now "increasingly converging". "That diversity of opportunity is a huge strength for Ireland," he told SiliconRepublic.com. "It allows people from different professional backgrounds to find meaningful, high-impact careers in healthcare, while helping Ireland move further up the value chain as a centre for complex, globally relevant innovation." Having recently expanded its Galway-based pharmaceutical laboratory, the Medtronic facility now serves as a west of Ireland hub for high-tech innovation and the evolving needs of the global healthcare space. Rogers is of the opinion that this is reflective of the convergence of the country's medtech divisions. Noting that the primary purpose of the lab "is to integrate pharmaceutical, engineering and analytical expertise under one roof to address the complex challenges of combination products, [that is] where a medical device and a medicine work together". "We see that convergence very clearly in this laboratory and there is a wide range of career paths in our industry, whether that's a pharmacist drawn to the faster innovation cycles and applied science of medtech, or a software developer who wants to use their skills to solve real healthcare challenges and code with a deeper sense of purpose." What opportunities exist? With the expansion comes the opportunity for students and professionals to consider a new role, either as part of Medtronic or within Galway's thriving life science and medtech spaces. "Galway offers a unique innovation ecosystem where infrastructure, academic partnerships and a significant medtech footprint all provide a strong foundation for sustaining Ireland's leadership in the life sciences sector," said Ruth Callanan, Medtronic's director of site quality. With the investment focused on significantly expanding R&D capability and technical depth within a critical space in the Irish medtech sector, Medtronic has increased lab space by almost a half and introduced analytical technologies that didn't exist there before. Callanan said: "This creates the conditions for future high-value work as programmes grow. It strengthens Galway's ability to attract and retain highly specialised talent, pharmaceutical scientists, chemical and materials engineers and it allows work that was previously outsourced internationally to be done here in Ireland. "Over time, as demand and activity scale, we do expect this capability to support additional specialist roles, phased in over the coming years. Importantly, it reinforces Ireland's position at the forefront of advanced medtech R&D and reflects a broader industry trend toward self-sufficiency in high-tech analytical testing." Step into the future. She explained the new lab will enable experts to integrate processes as the facility will be responsible for the entire life cycle of product development, from early phase R&D through to post-market oversight. She added: "The laboratory utilises advanced LCMS [liquid chromatography-mass spectrometry] and GCMS [gas chromatography-mass spectrometry] technologies, which act as 'molecular microscopes'. This allows our scientists to identify unknown compounds or impurities at extremely precise levels." According to Rogers, the new lab has a role to play in what he believes to be the reshaping of how STEM careers in Ireland are perceived and pursued, with Callanan noting this creates for students and professionals opportunities to engage with careers that bridge the gap between various scientific disciplines. "A laboratory of this size and complexity requires students and professionals with a wide range of skills and experience across multiple disciplines," she said. "Just as importantly," added Rogers, "we're sending a clear signal to pharmacists, chemists and analytical scientists that medtech offers deep, intellectually challenging career paths that go well beyond traditional manufacturing or even classical biomedical engineering." Laura Varley is the Careers editor for Silicon Republic

INACTIVE